Joseph Wolk compensation by year
JOHNSON & JOHNSON Summary Compensation Table · all 8 fiscal years held| Component | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Salary | $597,542 | $796,538 | $885,385 | $938,077 | $1,008,462 | $1,147,962 | $1,212,308 | $1,240,646 |
| Bonus | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 |
| Stock awards | $670,085 | $2,379,419 | $4,163,841 | $4,877,538 | $4,718,897 | $5,766,005 | $5,774,990 | $6,263,486 |
| Option awards | $216,898 | $1,182,003 | $1,448,997 | $1,688,997 | $1,841,952 | $2,460,014 | $2,634,006 | $2,470,503 |
| Non-equity incentive | $749,729 | $1,132,914 | $1,044,179 | $1,560,863 | $1,177,800 | $1,928,800 | $1,773,640 | $1,860,560 |
| Pension and deferred compensation | $441,000 | $1,925,000 | $2,607,000 | $1,809,897 | $0 | $2,514,000 | $1,124,000 | $2,455,025 |
| All other | $32,935 | $81,818 | $46,636 | $78,243 | $75,971 | $98,072 | $98,624 | $115,222 |
| Total | $2,708,189 | $7,497,692 | $10,196,038 | $10,953,615 | $8,823,082 | $13,914,853 | $12,617,568 | $14,405,442 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: JOHNSON & JOHNSON DEF 14A filed March 11, 2026, accession 0000200406-26-000063, and prior-year filings. Open the filing on EDGAR.
How this page was built: the JOHNSON & JOHNSON filed document, accession 0000200406-26-000063. Every figure is read from that document and cited to the page and table it appears in. Filed March 11, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 54,867 | $11,392,035 | — |
| RSU | 44,920 | $9,326,740 | — |
| RSU | 37,463 | $7,778,443 | — |
| RSU | 5,632 | $1,169,372 | — |
| RSU | 3,942 | $818,477 | — |
| RSU | 1,779 | $369,374 | — |
| Option | 91,277 | — | $156.15 |
| Option | 88,219 | — | $151.41 |
| Option | 79,280 | — | $165.89 |
| Option | 66,386 | — | $131.94 |
| Option | 63,464 | — | $157.92 |
| Option | 80,976 | — | $164.62 |
Per the Outstanding Equity Awards at Fiscal Year-End table in JOHNSON & JOHNSON's FY2025 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 15 award rows shown.
JOHNSON & JOHNSON’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joaquin Duato | Chairman/CEO | $32,758,111 |
| Joseph Wolk · this page | EVP, CFO | $14,405,442 |
| Jennifer Taubert | EVP, WWC Innovative Medicine | $14,030,063 |
| John Reed | EVP, Innovative Medicine, R&D | $12,214,062 |
| Tim Schmid | EVP, WWC, MedTech | $9,336,765 |
The full JOHNSON & JOHNSON compensation record
free company briefThis page is one person within JOHNSON & JOHNSON's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the JOHNSON & JOHNSON proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order JOHNSON & JOHNSON's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are JOHNSON & JOHNSON's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order JNJ
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.